Diarrhoea on Wegovy: separating the predictable from the concerning

Diarrhoea is a recognised, common side effect of Wegovy, most often appearing in the first few weeks or after a dose step-up, then settling.
Severe or persistent diarrhoea can cause dehydration — fluids matter and a pharmacist or GP should be contacted if it doesn't ease.
Pancreatitis is an uncommon but serious condition: severe stomach pain that reaches through to the back, with or without vomiting, needs same-day medical attention.
Suspected side effects (and any concerns about the source of your medicine) can be reported directly to the MHRA via the Yellow Card scheme.

Diarrhoea is one of the more common side effects of Wegovy (semaglutide), reported by a meaningful proportion of people during the early weeks of treatment or after each dose increase. For most, it is loose, brief and self-limiting — not a sign that something has gone seriously wrong. That said, knowing what a normal GI reaction looks like versus a signal that needs urgent attention is genuinely useful, so that's exactly what this page covers. Wegovy is a prescription-only medicine requiring clinical assessment; a prescriber decides whether it is right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding loose stools on Wegovy: the full picture from onset to management

The misconception worth correcting first: diarrhoea doesn't mean Wegovy has failed or isn't safe

The most common thing people assume when diarrhoea starts shortly after their first Wegovy pen is that something has gone wrong, either with the medicine or with them. In reality, the gastrointestinal system is responding to a drug that deliberately slows gastric emptying and alters gut-hormone signalling. The gut notices. That noticing, for many people, produces looser stools, more frequent trips to the bathroom, or an urgency they weren't expecting.

This pattern is well-documented in the clinical trial data. The NHS medicines page for semaglutide lists diarrhoea among the common side effects, alongside nausea, vomiting and constipation. It doesn't mean your body is rejecting the treatment. For most people, symptoms are mild to moderate and ease within one to two weeks as the gut adjusts to the new dose.

The broader context on Wegovy's side effect profile shows that GI effects are the most reported category across the board, and diarrhoea is no exception. Treating it as a signal to stop immediately (without speaking to your prescriber) means many people abandon a treatment that would have settled down on its own.

That is not the same as tolerating something severe. But the starting point is calibration, not alarm.

When diarrhoea on Wegovy tends to happen, and why dose changes matter

Timing is one of the clearest indicators of whether loose stools are treatment-related. Diarrhoea with Wegovy tends to cluster in two predictable windows: the first two to four weeks of starting the medicine at any dose, and the few days following a dose increase. The 0.25mg starting dose can cause it; so can the move to 0.5mg, 1.0mg, 1.7mg and 2.4mg, though sensitivity varies considerably between individuals.

The mechanism is straightforward. Semaglutide slows how quickly the stomach empties, which changes the transit time for food moving through the gut. That change affects the consistency of stools and can trigger an urgency response, particularly early on. As the gut adapts, the effect usually reduces.

Practically, the people who find diarrhoea from Wegovy most disruptive tend to be those who eat high-fat or very rich meals, since fat absorption is already affected. If you want a closer look at how Wegovy can cause diarrhoea and what drives the symptom, that page covers the mechanisms and management options in detail. Staying hydrated matters too, not just for comfort but because repeated loose stools can deplete fluids and electrolytes more quickly than people realise.

Your pen lives in the fridge, keep a glass of water nearby as a simple habit cue for hydration, especially in the first weeks of each new dose.

When to get medical help for diarrhoea and Wegovy

Most diarrhoea on Wegovy does not require a trip to A&E. But certain patterns do need prompt attention, and it is worth knowing them clearly before you need them.

Contact a pharmacist or your GP if diarrhoea is persistent (lasting more than a few days without improvement) or if you are showing signs of dehydration: a dry mouth, dark urine, dizziness or feeling faint. Children and older adults dehydrate faster, but anyone on Wegovy losing significant fluids should seek advice.

Call 999 or go to A&E if you develop severe, persistent abdominal pain that radiates towards your back, with or without vomiting. This can be a sign of acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a known but infrequent serious risk with GLP-1 medicines, including semaglutide, you can read it via the MHRA Drug Safety Update index. Diarrhoea alone is not pancreatitis, but when it accompanies that kind of abdominal pain, it should not be waited out at home.

Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash) also require emergency care immediately.

If something feels off but doesn't match the above, contact our support team or speak to your prescriber. Side effects and how to manage them are part of what aftercare is for.

Managing loose stools practically, and what to discuss with your prescriber

There is no single fix, but there are things that reliably help. Staying well hydrated is the most consistent recommendation, plain water, oral rehydration salts if needed. Eating smaller portions and avoiding very fatty, spicy or heavily processed foods during a period of GI sensitivity is worth trying before concluding that the medicine isn't tolerable.

Do not adjust your Wegovy dose yourself. If you are experiencing diarrhoea after a Wegovy injection and are questioning whether to continue, that is a conversation for your prescriber. Dose timing, whether a slower titration is possible, and whether a short pause is clinically appropriate are all things a prescriber can assess, the right call depends on your whole picture, not just the GI symptom in isolation.

For context on how semaglutide's GI side effects compare with those of tirzepatide, the semaglutide-specific diarrhoea page covers this in more detail, and our broader Wegovy overview explains how the medicine works and what the evidence shows. If you haven't started treatment yet, our prescribers discuss side effects and suitability as part of every consultation, you can check your eligibility and start your free consultation there.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions